Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Military
Boxing
Donald Trump
Social Media
World Cup
South America
Formula 1
Baseball
Soccer
Instagram
Immigration
Airstrike
Published • loading... • Updated

ImmunityBio’s ANKTIVA & FDA Expanded Access: Transforming bladder cancer treatment

Summary by Pharmaphorum
ImmunityBio’s ANKTIVA gains FDA Expanded Access authorisation—Dr Sandeep Reddy discusses its impact on bladder cancer and potential in other indications. Insights from ASCO 2025!

1 Articles

All
Left
Center
1
Right
PharmaphorumPharmaphorum
Center

ImmunityBio’s ANKTIVA & FDA Expanded Access: Transforming bladder cancer treatment

ImmunityBio’s ANKTIVA gains FDA Expanded Access authorisation—Dr Sandeep Reddy discusses its impact on bladder cancer and potential in other indications. Insights from ASCO 2025!

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Pharmaphorum broke the news in on Thursday, June 12, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal